BIOTECHNOLOGY ULTRASECTOR PROFUND (BIPIX) is an MF managed by Independent / Boutique. Its largest position is APPLIED MATERIALS INC /DE (AMAT), representing 8.47% of fund assets.
BIOTECHNOLOGY ULTRASECTOR PROFUND Portfolio Holdings
Source: SEC Form N-PORT institutional portfolio disclosures
- Ticker:
- BIPIX
- Type:
- MF
- Manager:
- Independent / Boutique
- Total Assets:
- —
- Report Date:
- Apr 30, 2026
- Filing Date:
- Jun 22, 2026
| Holding | Weight | Market Value | Shares |
|---|---|---|---|
|
-
APPLIED MATERIALS INC /DE
|
8.47% | $15,471,000.00 | 15,471,000 |
|
-
APPLIED MATERIALS INC /DE
|
7.20% | $13,150,000.00 | 13,150,000 |
|
-
APPLIED MATERIALS INC /DE
|
6.36% | $11,603,000.00 | 11,603,000 |
|
-
APPLIED MATERIALS INC /DE
|
4.24% | $7,735,000.00 | 7,735,000 |
|
-
APPLIED MATERIALS INC /DE
|
2.11% | $3,847,000.00 | 3,847,000 |
|
-
INVESCO GOVERNMENT & AGENCY PORTFOLIO
|
2.05% | $3,746,290.00 | 3,746,290 |
|
-
APPLIED MATERIALS INC /DE
|
1.48% | $2,707,000.00 | 2,707,000 |
|
-
APELLIS PHARMACEUTICALS INC
|
1.35% | $2,461,791.15 | 60,117 |
|
-
Revolution Medicines, Inc.
|
1.19% | $2,174,338.44 | 15,087 |
|
-
Travere Therapeutics, Inc.
|
1.17% | $2,138,727.24 | 50,777 |
|
-
ARROWHEAD PHARMACEUTICALS, INC.
|
1.04% | $1,900,192.80 | 25,860 |
|
-
Twist Bioscience Corp
|
1.03% | $1,874,082.35 | 32,063 |
|
-
Summit Therapeutics Inc.
|
1.01% | $1,852,019.46 | 86,301 |
|
-
Alkermes plc.
|
1.00% | $1,823,879.55 | 54,105 |
|
-
TG THERAPEUTICS, INC.
|
0.99% | $1,809,425.70 | 53,565 |
|
-
MADRIGAL PHARMACEUTICALS, INC.
|
0.99% | $1,801,551.98 | 3,482 |
|
-
Beam Therapeutics Inc.
|
0.96% | $1,747,341.63 | 57,611 |
|
-
APOGEE THERAPEUTICS INC
|
0.91% | $1,667,663.91 | 20,119 |
|
-
Scholar Rock Holding Corp
|
0.89% | $1,621,841.56 | 34,796 |
|
-
Praxis Precision Medicines, Inc.
|
0.88% | $1,612,960.97 | 5,059 |
|
-
EXELIXIS, INC.
|
0.88% | $1,600,026.48 | 35,988 |
|
-
Mirum Pharmaceuticals, Inc.
|
0.87% | $1,593,548.56 | 16,376 |
|
-
UNITED THERAPEUTICS Corp
|
0.86% | $1,575,783.30 | 2,758 |
|
-
Natera, Inc.
|
0.86% | $1,575,474.72 | 7,642 |
|
-
CRISPR Therapeutics AG
|
0.86% | $1,575,015.28 | 30,092 |
|
-
Celcuity Inc.
|
0.86% | $1,575,001.65 | 12,979 |
|
-
Krystal Biotech, Inc.
|
0.85% | $1,545,235.92 | 5,892 |
|
-
Protagonist Therapeutics, Inc
|
0.84% | $1,541,259.81 | 15,573 |
|
-
NEUROCRINE BIOSCIENCES INC
|
0.84% | $1,527,240.33 | 11,599 |
|
-
INCYTE CORP
|
0.83% | $1,512,220.71 | 15,873 |
|
-
CG Oncology, Inc.
|
0.83% | $1,511,327.30 | 22,645 |
|
-
CYTOKINETICS INC
|
0.83% | $1,510,523.61 | 23,613 |
|
-
NUVALENT INC-A
|
0.82% | $1,505,904.76 | 15,017 |
|
-
IONIS PHARMACEUTICALS INC
|
0.82% | $1,501,853.64 | 20,089 |
|
-
BridgeBio Pharma, Inc.
|
0.82% | $1,496,581.06 | 21,046 |
|
-
Vaxcyte, Inc.
|
0.82% | $1,494,937.08 | 26,117 |
|
-
Kymera Therapeutics, Inc.
|
0.82% | $1,494,201.17 | 18,431 |
|
-
BIOGEN INC.
|
0.82% | $1,493,040.64 | 7,888 |
|
-
Cogent Biosciences, Inc.
|
0.82% | $1,490,402.97 | 41,643 |
|
-
PTC THERAPEUTICS, INC.
|
0.82% | $1,488,507.74 | 22,879 |
|
-
INSMED Inc
|
0.80% | $1,469,364.74 | 10,778 |
|
-
ALNYLAM PHARMACEUTICALS, INC.
|
0.79% | $1,451,198.61 | 4,689 |
|
-
Roivant Sciences Ltd.
|
0.79% | $1,449,152.82 | 50,794 |
|
-
HALOZYME THERAPEUTICS, INC.
|
0.79% | $1,438,779.66 | 22,601 |
|
-
Arcutis Biotherapeutics, Inc.
|
0.78% | $1,415,653.74 | 60,967 |
|
-
Spyre Therapeutics, Inc.
|
0.77% | $1,411,646.45 | 18,961 |
|
-
SOLENO THERAPEUTICS INC
|
0.77% | $1,400,944.86 | 26,523 |
|
-
AbbVie Inc.
|
0.76% | $1,394,500.68 | 6,599 |
|
-
AMGEN INC
|
0.75% | $1,377,728.75 | 3,979 |
|
-
REGENERON PHARMACEUTICALS, INC.
|
0.75% | $1,371,696.40 | 1,940 |
Advertisement (320x50)